Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2009-02-06

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.bbrc.2008.12.122PMID 19121627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly(γ‐glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: Potential for an AIDS vaccine

  2008cited by this paper
• Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells.

  2008cited by this paper
• Induction of Potent CD8+ T-Cell Responses by Novel Biodegradable Nanoparticles Carrying Human Immunodeficiency Virus Type 1 gp120

  2007cited by this paper
• Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles.

  2007cited by this paper
• Targeting of Antigen to Dendritic Cells with Poly(γ-Glutamic Acid) Nanoparticles Induces Antigen-Specific Humoral and Cellular Immunity1

  2007cited by this paper
• Efficient Capture of Antibody Neutralized HIV-1 by Cells Expressing DC-SIGN and Transfer to CD4+ T Lymphocytes12

  2007cited by this paper
• Exploiting lymphatic transport and complement activation in nanoparticle vaccines

  2007cited by this paper
• Nanoparticles and microparticles as vaccine-delivery systems

  2007cited by this paper
• Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes1

  2006cited by this paper
• Targeting the innate immune response with improved vaccine adjuvants

  2005cited by this paper
• In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid).

  2005cited by this paper
• Potent activation of antigen-specific T cells by antigen-loaded nanospheres.

  2005cited by this paper
• Vaccine adjuvants: Current state and future trends

  2004cited by this paper
• Progress in DNA‐based heterologous prime‐boost immunization strategies for malaria

  2004cited by this paper
• CD8 T Cells Inhibit IgE Via Dendritic Cell IL-12 Induction That Promotes Th1 T Cell Counter-Regulation1

  2002cited by this paper
• Prospects for vaccine protection against HIV-1 infection and AIDS.

  2002cited by this paper
• Studies Using Leukemia Inhibitory Factor (LIF) Knockout Mice and a LIF Adenoviral Vector Demonstrate a Key Anti-Inflammatory Role for This Cytokine in Cutaneous Inflammation1

  2001cited by this paper
• Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

  1999cited by this paper
• Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

  1998cited by this paper

• Cationic versus Anionic Chitosan Nanogels as Adjuvants for Hepatitis B Vaccine: Effect of Surface Charge on Immune Enhancement

  2026cites this paper
• Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination.

  2023cites this paper
• Production and applications of polyglutamic acid

  2021cites this paper
• Studies on prerequisites for antigen-specific active immunotherapy

  2020cites this paper
• Polymers for subunit vaccine delivery

  2019cites this paper
• Vaccine Lipid-Biopolymer Cross-Linked Nanoparticles Against Infectious Diseases and Cancer

  2019cites this paper
• Chapter 9: Update on Nanoparticle‒Mediated Immune Mechanisms for Dendritic Cell-Based Targeted Immunity and Cancer

  2017cites this paper
• Polymers in Nanomedicine - ReadingSample

  2017cites this paper
• Design of pH-sensitive polymer-modified liposomes for antigen delivery and their application in cancer immunotherapy

  2016cites this paper
• Induction of Potent Adaptive Immunity by the Novel Polyion Complex Nanoparticles

  2015cites this paper
• Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens.

  2015cites this paper
• Peptides for immunological purposes: design, strategies and applications

  2013cites this paper
• Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.

  2013cites this paper
• Biodistribution of (125)I-labeled polymeric vaccine carriers after subcutaneous injection.

  2013cites this paper
• Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo.

  2013cites this paper
• Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.

  2013cites this paper
• in Immunology Uptake of biodegradable poly( γ -glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo (cid:2)

  2013cites this paper
• An investigation into the potential use of nanoparticles as adjuvants for the production of polyclonal antibodies to low molecular weight compounds.

  2012cites this paper
• Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.

  2012cites this paper
• Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine

  2011cites this paper
• Poly (glutamic acid)--an emerging biopolymer of commercial interest.

  2011cites this paper
• 12 – Injectable nanotechnology

  2011cites this paper
• Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in mice.

  2011cites this paper
• In Vivo Modulation of Dendritic Cells by Engineered Materials: Towards New Cancer Vaccines.

  2011cites this paper
• Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.

  2011cites this paper
• EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor

  2010cites this paper
• Modulation of Gene Expression Related to Toll-Like Receptor Signaling in Dendritic Cells by Poly(γ-Glutamic Acid) Nanoparticles

  2010cites this paper
• Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus.

  2010cites this paper
• Pharmaceutical and Medical Applications of Poly-Gamma-Glutamic Acid

  2010cites this paper
• Modulation of innate and adaptive immunity by biodegradable nanoparticles.

  2009cites this paper
• Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens.

  2009cites this paper